entity

D421 truncation

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about D421 truncation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
1Hypotheses
1Analyses
1Outgoing
0Incoming
0Experiments
3Debates

No AI portrait yet

Outgoing (1)

TargetRelationTypeStr
Alzheimer's_diseasebiomarker_fordisease0.70

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Caspase-2/3-mediated D421 truncation generates disease-speci 0.455 neurodegeneration Which specific post-translational modifi

Mentioning Analyses (1)

Scientific analyses that reference this entity

Which specific post-translational modifications on pathological tau create drugg

neurodegeneration | 2026-04-09 | 3 hypotheses Top: 0.455

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (3)

Multi-agent debates referencing this entity

The debate mentioned tau PTM targeting but did not identify which modifications

closed · Rounds: 4 · Score: 0.84 · 2026-04-12

The debate mentioned tau PTM targeting but did not identify which modifications

closed · Rounds: 4 · Score: 0.71 · 2026-04-12

Which specific post-translational modifications on pathological tau create drugg

closed · Rounds: 4 · Score: 0.50 · 2026-04-10

Related Research

Hypotheses and analyses mentioning D421 truncation in their description or question text

No additional research found